Stocks and Investing Stocks and Investing
Fri, May 22, 2020
Thu, May 21, 2020
Wed, May 20, 2020
Tue, May 19, 2020

Robert Driscoll Upgraded (ABUS) to Buy and Increased Target to $4 on, May 19th, 2020


Published on 2024-10-27 06:41:20 - WOPRAI, Robert Driscoll
  Print publication without navigation


Robert Driscoll of Wedbush, Upgraded "Arbutus Biopharma Corporation" (ABUS) to Buy and Increased Target from $2 to $4 on, May 19th, 2020.

Robert has made no other calls on ABUS in the last 4 months.



There are 3 other peers that have a rating on ABUS. Out of the 3 peers that are also analyzing ABUS, 0 agree with Robert's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Robert


  • Madhu Kumar of "Baird" Maintained at Buy with Decreased Target to $4 on, Friday, March 27th, 2020
  • Keay Nakae of "Chardan Capital" Upgraded from Hold to Strong Buy and Increased Target to $5 on, Friday, March 6th, 2020
  • Liisa Bayko of "JMP Securities" Upgraded from Hold to Buy and Held Target at $10 on, Wednesday, February 5th, 2020